Investor Relations
Press Releases
March 14, 2024
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
February 26, 2024
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
February 12, 2024
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition